
Tivenix is a Swiss company specializing in AI-powered diagnostic software for neurodegenerative diseases, primarily Alzheimer's disease. Their proprietary platform analyzes complex epigenetic patterns in plasma to provide accurate, non-invasive diagnosis and monitor disease progression and treatment response. The technology integrates data from various biomarkers and is supported by clinical evidence demonstrating its accuracy. The company is advancing validation studies and expanding its scope to other neurodegenerative disorders. Tivenix operates with a team of experts in neuroscience, biotechnology, data science, and software engineering, aiming to improve diagnosis and patient outcomes globally.

Tivenix is a Swiss company specializing in AI-powered diagnostic software for neurodegenerative diseases, primarily Alzheimer's disease. Their proprietary platform analyzes complex epigenetic patterns in plasma to provide accurate, non-invasive diagnosis and monitor disease progression and treatment response. The technology integrates data from various biomarkers and is supported by clinical evidence demonstrating its accuracy. The company is advancing validation studies and expanding its scope to other neurodegenerative disorders. Tivenix operates with a team of experts in neuroscience, biotechnology, data science, and software engineering, aiming to improve diagnosis and patient outcomes globally.